Saravay SM, Kaplowitz M, Kurek J, et al. How do delirium and dementia increase length of stay of elderly generalmedical inpatients.Psychosomatics, 2004, 45(3): 235-242. Liu GJ, Wang ZJ, Wang YF, et al. Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Eur J Clin Pharmacol, 2012, 68(2): 131-139. 王晓明,徐忠信,莽靖,等. 慢性脑缺血致认知功能障碍大鼠皮层Rho激酶表达变化. 中国老年学杂志, 2009, 4(29): 944-945. 于凤芹,彭海,杨艳飞,等.RhoA/Rho 激酶信号通路对小鼠抗衰老Klotho蛋白表达的影响.卒中与神经疾病,2010,17(1): 3-5. Zhao J, Zhou D, Guo J, et al. Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine. Neurol Med Chir (Tokyo), 2011, 51(10): 679-683. Hahmann C, Schroeter T. Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity. Cell Mol Life Sci, 2010, 67(2): 171-177. Zhou Q, Gensch C, Liao JK. Rhoassociated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease. Trends Pharmacol Sci, 2011, 32(3): 167-173. Olson MF. Applications for ROCK kinase inhibition. Curr Opin Cell Biol, 2008, 20(2): 242-248.